Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.22
Delayed Data
As of May 22
 0.00 / 0.00%
Today’s Change
0.77
Today|||52-Week Range
1.88
+23.35%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close1.22
Today’s open1.24
Day’s range1.20 - 1.25
Volume1,191,784
Average volume (3 months)2,594,493
Market cap$53.9M
Dividend yield--
Data as of 4:00pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+82.79%
Earnings growth (this year)--
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-9.63%
P/E ratio2.0
Price/Sales1.54
Price/Book1.82

Competitors

 Today’s
change
Today’s
% change
HTBXHeat Biologics Inc+0.12+1.90%
PARNParnell Pharmaceutic...+0.11+2.66%
ADMPAdamis Pharmaceutica...+0.05+1.25%
HEBHemispherx Biopharma...-0.00-2.09%
Data as of 4:00pm ET, 05/22/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$31.2M
Annual profit (last year)$28.8M
Net profit margin92.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, COO &
Secretary
George W. Hebard
Chief Financial Officer &
Vice President
Richard L. Feinstein
Corporate headquarters
Piscataway, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers